These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 513712)

  • 21. Poly(DL-lactide-co-glycolide)/norethisterone microcapsules: an injectable biodegradable contraceptive.
    Beck LR; Pope VZ; Flowers CE; Cowsar DR; Tice TR; Lewis DH; Dunn RL; Moore AB; Gilley RM
    Biol Reprod; 1983 Feb; 28(1):186-95. PubMed ID: 6830939
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Radioimmunoassay system for norethisterone using 3H- and 125I-labelled radioligands.
    Morris SE; Cameron EH
    J Steroid Biochem; 1975 Jul; 6(7):1145-50. PubMed ID: 1177442
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of the norethisterone minipill on the plasma levels of biologically and immunologically active luteinizing hormone in women.
    Balogh A; Robertson DM; Diczfalusy E
    Acta Endocrinol (Copenh); 1979 Nov; 92(3):428-36. PubMed ID: 517047
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of daily norethisterone (0.35 mg) on cervical mucus and on urinary LH, pregnanediol and oestrogen levels.
    Elstein M; Briston PG; Hewitt KJ; Kirk D; Miller H
    Br J Obstet Gynaecol; 1976 Feb; 83(2):165-8. PubMed ID: 1032819
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of norethisterone and levonorgestrel in low-dose multiphasic oral contraceptives on serum lipids.
    Wiik P; Nordby J; Paulsen JE
    Acta Obstet Gynecol Scand; 1993 Oct; 72(7):550-5. PubMed ID: 8213103
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Insulin resistance, secretion, and metabolism in users of oral contraceptives.
    Godsland IF; Walton C; Felton C; Proudler A; Patel A; Wynn V
    J Clin Endocrinol Metab; 1992 Jan; 74(1):64-70. PubMed ID: 1530790
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma levels of adrenocorticotropin and cortisol in women receiving oral contraceptive steroid treatment.
    Carr BR; Parker CR; Madden JD; MacDonald PC; Porter JC
    J Clin Endocrinol Metab; 1979 Sep; 49(3):346-9. PubMed ID: 224073
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of oral contraceptives on plasma glucose, insulin, and glucagon levels.
    Gossain VV; Sherma NK; Michelakis AM; Rovner DR
    Am J Obstet Gynecol; 1983 Nov; 147(6):618-23. PubMed ID: 6356926
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of topiramate on the pharmacokinetics of an oral contraceptive containing norethindrone and ethinyl estradiol in patients with epilepsy.
    Rosenfeld WE; Doose DR; Walker SA; Nayak RK
    Epilepsia; 1997 Mar; 38(3):317-23. PubMed ID: 9070594
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insulin sensitivity is decreased in normal women by doses of ethinyl estradiol used in oral contraceptives.
    Kojima T; Lindheim SR; Duffy DM; Vijod MA; Stanczyk FZ; Lobo RA
    Am J Obstet Gynecol; 1993 Dec; 169(6):1540-4. PubMed ID: 8267059
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Subcutaneous bioabsorbable pellets of norethindrone for contraception in women: Phase I. Clinical study.
    Gupta GN; Saxena BB; Landesman R; Ledger WJ
    Fertil Steril; 1984 May; 41(5):726-31. PubMed ID: 6714449
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical evaluation of injectable biodegradable contraceptive system.
    Beck LR; Ramos RA; Flowers CE; Lopez GZ; Lewis DH; Cowsar DR
    Am J Obstet Gynecol; 1981 Aug; 140(7):799-806. PubMed ID: 7020421
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A prospective controlled study of the effect on blood pressure of contraceptive preparations containing different types and dosages of progestogen.
    Wilson ES; Cruickshank J; McMaster M; Weir RJ
    Br J Obstet Gynaecol; 1984 Dec; 91(12):1254-60. PubMed ID: 6440589
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of nanogram quantities of norethisterone in plasma using a GC-MS-COM selective ion detection procedure.
    Stillwell WG; Stillwell RN; Horning EC
    Steroids Lipids Res; 1974; 5(2):79-90. PubMed ID: 4428492
    [TBL] [Abstract][Full Text] [Related]  

  • 35. d-Norgestrel concentrations in maternal plasma, milk, and child plasma during administration of oral contraceptives to nursing women.
    Nilsson S; Nygren KG; Johansson ED
    Am J Obstet Gynecol; 1977 Sep; 129(2):178-84. PubMed ID: 900181
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A simple high-throughput enzymeimmunoassay for norethisterone (norethindrone).
    Turkes A; Read GF; Riad-Fahmy D
    Contraception; 1982 May; 25(5):505-14. PubMed ID: 7049571
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The metabolic clearance rate and urinary excretion of oral contraceptive drugs. I. Norethindrone.
    Mills TM; Lin TJ; Hernandez-Ayup S; Greenblatt RB; Ellegood JO; Mahesh VB
    Am J Obstet Gynecol; 1974 Nov; 120(6):764-72. PubMed ID: 4429084
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Contraceptive efficacy, pharmacokinetics, and safety of Annuelle biodegradable norethindrone pellet implants.
    Raymond EG; Singh M; Archer DF; Saxena BB; Baker J; Cole D
    Fertil Steril; 1996 Dec; 66(6):954-61. PubMed ID: 8941061
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prospective study of carbohydrate metabolism in women using a triphasic oral contraceptive containing norethindrone and ethinyl estradiol for 3 months.
    Spellacy WN; Ellingson AB; Kotlik A; Tsibris JC
    Am J Obstet Gynecol; 1988 Oct; 159(4):877-9. PubMed ID: 3052079
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The characterization of sulphated metabolites of norethindrone in human milk after oral administration of contraceptive steroids.
    Sahlberg BL
    J Steroid Biochem; 1987 Apr; 26(4):481-5. PubMed ID: 3586665
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.